Sunflower Pharmaceuticals Group Co Ltd (002737) — Financial Flexibility Index
Sunflower Pharmaceuticals Group Co Ltd (002737) has a Financial Flexibility Index of -0.08x as of September 2025. Free cash flow of CN¥-71.93 Million (operating CF CN¥-117.97 Million minus capex CN¥46.03 Million) represents 0% of total liabilities (CN¥891.55 Million). Check how strategically is Sunflower Pharmaceuticals Group Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sunflower Pharmaceuticals Group Co Ltd Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Sunflower Pharmaceuticals Group Co Ltd across 15 annual periods. See working capital position of Sunflower Pharmaceuticals Group Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sunflower Pharmaceuticals Group Co Ltd (2011–2025)
Year-by-year free cash flow to debt coverage for Sunflower Pharmaceuticals Group Co Ltd. For the full company profile including market capitalisation, see Sunflower Pharmaceuticals Group Co Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | CN¥671.07 Million | CN¥574.97 Million | CN¥1.34 Billion | ▲ +388.8% |
| 2024 | -0.17x | CN¥-214.69 Million | CN¥-307.48 Million | CN¥1.24 Billion | ▼ -130.4% |
| 2023 | 0.57x | CN¥1.07 Billion | CN¥923.30 Million | CN¥1.88 Billion | ▼ -30.2% |
| 2022 | 0.82x | CN¥2.12 Billion | CN¥1.97 Billion | CN¥2.59 Billion | ▲ +41.6% |
| 2021 | 0.58x | CN¥983.54 Million | CN¥865.23 Million | CN¥1.70 Billion | ▼ -27.9% |
| 2020 | 0.80x | CN¥1.38 Billion | CN¥1.17 Billion | CN¥1.72 Billion | ▲ +11.3% |
| 2019 | 0.72x | CN¥1.36 Billion | CN¥981.33 Million | CN¥1.88 Billion | ▼ -1.4% |
| 2018 | 0.73x | CN¥1.19 Billion | CN¥866.21 Million | CN¥1.62 Billion | ▲ +33.8% |
| 2017 | 0.55x | CN¥715.65 Million | CN¥558.77 Million | CN¥1.31 Billion | ▲ +55.0% |
| 2016 | 0.35x | CN¥500.72 Million | CN¥341.23 Million | CN¥1.42 Billion | ▲ +34.3% |
| 2015 | 0.26x | CN¥303.16 Million | CN¥125.84 Million | CN¥1.15 Billion | ▼ -36.5% |
| 2014 | 0.41x | CN¥600.94 Million | CN¥403.23 Million | CN¥1.45 Billion | ▲ +4.2% |
| 2013 | 0.40x | CN¥487.78 Million | CN¥293.34 Million | CN¥1.23 Billion | ▲ +2.1% |
| 2012 | 0.39x | CN¥441.53 Million | CN¥327.31 Million | CN¥1.14 Billion | ▼ -13.7% |
| 2011 | 0.45x | CN¥456.70 Million | CN¥257.60 Million | CN¥1.01 Billion | — |